Extrapulmonary neoplasms in lung cancer screening

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Lung cancer screening in Canada

The potential value of screening for lung cancer with low-dose CT scans is currently a topic of much research and debate. This article reviews the existing trials of lung cancer screening, using chest x-ray and low-dose CT scan. Potential harms of screening, including overdiagnosis and radiation exposure, are addressed. Practical difficulties of organizing a screening program in Canada include ...

متن کامل

[Screening for lung cancer].

The authors give an overview about the novel results and shifting paradigm of lung cancer screening. They also summarize the results of previous and most recent clinical trials, which re-directed the international interest on lung cancer screening.

متن کامل

Lung cancer screening update

Low-dose computed tomography (ld-CT) for lung cancer screening in high-risk subjects is performed within clinical trials and has started to be used in routine clinical practice. The technique is well defined, even if some methodological problems are still debated, such as the measurements of pulmonary nodules, the size to define them as clinically significant, the management of small or non-sol...

متن کامل

Lung cancer screening update

Lung cancer is the leading cause of cancer-related mortality globally and the American cancer society estimates approximately 226,160 new cases and 160,340 deaths from lung cancer in the USA in the year 2012. The majority of lung cancers are diagnosed in the later stages which impacts the overall survival. The 5-year survival rate for pathological st age IA lung cancer is 73% but drops to only ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Translational Lung Cancer Research

سال: 2018

ISSN: 2218-6751,2226-4477

DOI: 10.21037/tlcr.2018.06.05